Study Stopped
Inclusion issues
Impact of Multisensory Hand Massage on the Well-being of Cancer Patients
ONCOTACT
1 other identifier
interventional
9
1 country
1
Brief Summary
The investigators wish to study the impact of a multisensory hand massage on the immediate well-being of cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
Started Sep 2019
Typical duration for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2019
CompletedFirst Posted
Study publicly available on registry
May 10, 2019
CompletedStudy Start
First participant enrolled
September 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 11, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 11, 2022
CompletedNovember 28, 2022
September 1, 2022
3.1 years
May 9, 2019
November 22, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change in well-being following multisensory massage
EValuation Immédiate du Bien-Etre (EVIBE) questionnaire: 1-5 pictorial scale with 1 being lowest
30 minutes
Secondary Outcomes (8)
Well-being following multisensory massage
2 hours
Well-being following multisensory massage
4 hours
Well-being following multisensory massage
6 hours
Well-being following multisensory massage
8 hours
Patient anxiety
Immediately prior to treatment
- +3 more secondary outcomes
Study Arms (2)
Multisensory massage
EXPERIMENTALControl
NO INTERVENTIONInterventions
7 minutes of hand massage followed by multisensory immersion (lights and music) for 23 minutes
Eligibility Criteria
You may qualify if:
- The patient must have given their free and informed consent and signed the consent form
- The patient must be a member or beneficiary of a health insurance plan
- Patient treated in the oncology department of CHU Nimes for any form of cancer with an EValuation Immédiate du Bien-Etre (EVIBE) score of 3 or lower
You may not qualify if:
- The subject refuses to sign the consent
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- Patient allergic to the massage oil
- Patients with visual or auditory problems
- Patients with an infection resulting in hyperthermia
- Patient with hematoma on the hand
- Patient with dermatological problems or painful areas on the hands
- Patients with an EVIBE score greater than 3
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nimes
Nîmes, 30029, France
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Nadine Houede, MD
CHU Nimes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2019
First Posted
May 10, 2019
Study Start
September 17, 2019
Primary Completion
October 11, 2022
Study Completion
October 11, 2022
Last Updated
November 28, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share